In subjects at intermediate risk of CVD, incorporation of CRP to a model of assessment of CV risk improves the prognostic power for myocardial infarction presentation (66), and could help prevent 1 additional CV event in 10 years from 400–500 screened subjects (12). This evidence concerns the gene CRP and myocardial infarction.